Keywords: italy, menarini, pay, up, million, rights, cv

Italy's Menarini to pay up to $385 million for rights to CV Thera's Ranexa

Article | 22 September 2008

Print This

Italy's largest pharmaceutical company, the privately-held Menarini Group, has entered into an agreement with US firm CV Therapeutics to gain ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in